Eyenovia
12.29.20
Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombiSource: Eyenovia
12.16.20
Eyenovia Announces First Patients Enrolled in Phase 3 Study of MicroLine for PresbyopiaSource: Eyenovia
12.03.20
FDA Approves Eyenovia’s IND Application for MicroLine for Presbyopia, Allowing for Phase 3 TrialsSource: Eyenovia
10.08.20
Eyenovia to Present Clinical Study Updates at the American Academy of Optometry Annual MeetingSource: Eyenovia
06.05.19
Eyenovia Enrolls First Patient in Phase 3 CHAPERONE Study for Progressive MyopiaSource: Eyenovia
05.06.19
Eyenovia Announces Presentation of Successful Phase 3 Studies at the ASCRSSource: Eyenovia
02.25.19
Eyenovia Announces Confirmatory Results from Second MicroStat Phase 3 Registration Study for MydriasisSource: Eyenovia